OncoSeq® X combines the power of NGS to sequence the genes and and Microarray technology to cover the hotspots in the genes involved to help patients determine their hereditary predisposition to developing cancer. Using both technologies, genes, & hotspots within genes, OncoSeq X assures wider coverage and better results.
Identifying these variations early is important to determine
strategies for prevention, early detection, and planning of treatment
if necessary.